Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity
Abstract Background Semen is a critical vector for human immunodeficiency virus (HIV) sexual transmission and harbors seminal amyloid fibrils that can markedly enhance HIV infection. Semen-derived enhancer of viral infection (SEVI) is one of the best-characterized seminal amyloid fibrils. Due to the...
Main Authors: | Ruxia Ren, Shuwen Yin, Baolong Lai, Lingzhen Ma, Jiayong Wen, Xuanxuan Zhang, Fangyuan Lai, Shuwen Liu, Lin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Retrovirology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12977-018-0432-3 |
Similar Items
-
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG
by: Hartjen Philip, et al.
Published: (2012-01-01) -
Enhancement of Herpes Simplex Virus (HSV) Infection by Seminal Plasma and Semen Amyloids Implicates a New Target for the Prevention of HSV Infection
by: Lilith Torres, et al.
Published: (2015-04-01) -
Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
by: Ryszard Pluta, et al.
Published: (2021-01-01) -
Synthesis and biological activity of myricetin derivatives containing 1,3,4-thiadiazole scaffold
by: Xinmin Zhong, et al.
Published: (2017-10-01) -
Anti-tumor effects and associated molecular mechanisms of myricetin
by: Min Jiang, et al.
Published: (2019-12-01)